Authorization of the financial statements

April 23, 2026

Management board

Franca Vossen, Chief Risk Officer

Huib-Jan de Ruijter, Co-Chief Investment Officer

Michael Jongeneel, Chief Executive Officer, Chief Finance & Officer a.i.